KUALA LUMPUR, MY / ACCESS Newswire / May 13, 2026 / AsiaFIN Holdings Corp., (OTCQB:ASFH), a leading fintech financial ecosystem enabler, today announced financial results for the first quarter of 2026 ...
Northland Power Inc. ("Northland" or the "Company") (TSX: NPI) today reported financial results for the three months ended ...
The Company announced today that it has submitted information required to demonstrate compliance with the Nasdaq Capital Market's stockholders' equity requirement within the remediation period granted ...
ASMFC decision to return Draft Addendum II for further development is responsible due diligence WASHINGTON, DC / ACCESS ...
PHILADELPHIA, PA / ACCESS Newswire / May 13, 2026 / Action Behavior Centers (ABC), a leading provider of evidence-based ...
Through this collaboration, the service provider will strengthen its operational resilience, improve service agility, and enhance customer experiences JERSEY CITY, NJ / ACCESS Newswire / May 13, 2026 ...
Vital Infrastructure Property Trust (TSX: VITL.UN) ("Vital Infrastructure" or the "REIT") today announced its first quarter results for the three ...
First Quarter HighlightsPer Class B share(3): $1.20 adjusted basic earnings up 1.7%; $1.18 basic earnings per share even to first quarter 2025; currency translation negligibleSales increased 2.8% on 1 ...
May 2026 - Theon International Plc (THEON) is pleased to announce a $3 million strategic investment in Twin Prime, a US-based frontier ...
The inventory modernization will enhance operational efficiency and accelerate network planning, rollout, and assurance for Vodafone Ireland, ensuring future readiness while aligning with the broader ...
Not for distribution to United States Newswire Services or for dissemination in the United States VICTORIA, BC / ACCESS Newswire / May 13, 2026 / BEACN Wizardry & Magic Inc. (TSX-V:BECN) ("BEACN" or t ...
Investigational New Drug application for KHN921 received "study may proceed" from the US FDA. KHN921 is a potential "first-in-class" cardiovascular AAV gene therapy being developed for the treatment o ...